<?xml version="1.0" encoding="utf-8" standalone="no"?>
<billStatus>
  <version>3.0.0</version>
  <bill>
    <number>7188</number>
    <updateDate>2025-05-27T14:14:18Z</updateDate>
    <updateDateIncludingText>2025-05-27T14:14:18Z</updateDateIncludingText>
    <originChamber>House</originChamber>
    <originChamberCode>H</originChamberCode>
    <type>HR</type>
    <introducedDate>2024-02-01</introducedDate>
    <congress>118</congress>
    <cdata>
      <constitutionalAuthorityStatementText>&lt;pre&gt;[Congressional Record Volume 170, Number 19 (Thursday, February 1, 2024)][House][Pages H388-H389]From the Congressional Record Online through the Government Publishing Office [&lt;a href="https://www.gpo.gov"&gt;www.gpo.gov&lt;/a&gt;]By Mr. MOOLENAAR:H.R. 7188.Congress has the power to enact this legislation pursuantto the following:[[Page H389]]Article I, Section 8, Clause 3: To regulate commerce withforeign nations, and among the several states, and with theIndian tribes;The single subject of this legislation is:This legislation would enhance initiatives to preventtuberculosis outbreaks from infected donor cell and tissueproducts through public awareness campaigns and civilpenalties for public health violations.&lt;/pre&gt;</constitutionalAuthorityStatementText>
    </cdata>
    <committees>
      <item>
        <systemCode>hsif00</systemCode>
        <name>Energy and Commerce Committee</name>
        <chamber>House</chamber>
        <type>Standing</type>
        <subcommittees>
          <item>
            <systemCode>hsif14</systemCode>
            <name>Health Subcommittee</name>
            <activities>
              <item>
                <name>Reported by</name>
                <date>2024-05-16T15:15:24Z</date>
              </item>
              <item>
                <name>Markup by</name>
                <date>2024-05-16T15:15:10Z</date>
              </item>
              <item>
                <name>Referred to</name>
                <date>2024-02-02T21:41:35Z</date>
              </item>
            </activities>
          </item>
        </subcommittees>
        <activities>
          <item>
            <name>Reported By</name>
            <date>2024-11-22T18:58:19Z</date>
          </item>
          <item>
            <name>Markup By</name>
            <date>2024-09-18T13:51:57Z</date>
          </item>
          <item>
            <name>Referred To</name>
            <date>2024-02-01T14:02:15Z</date>
          </item>
        </activities>
      </item>
    </committees>
    <committeeReports>
      <committeeReport>
        <citation>H. Rept. 118-766</citation>
      </committeeReport>
    </committeeReports>
    <relatedBills>
      <item>
        <title>Shandra Eisenga Human Cell and Tissue Product Safety Act</title>
        <congress>118</congress>
        <number>3733</number>
        <type>S</type>
        <latestAction>
          <actionDate>2024-02-05</actionDate>
          <text>Read twice and referred to the Committee on Health, Education, Labor, and Pensions.</text>
        </latestAction>
        <relationshipDetails>
          <item>
            <type>Identical bill</type>
            <identifiedBy>CRS</identifiedBy>
          </item>
        </relationshipDetails>
      </item>
    </relatedBills>
    <actions>
      <item>
        <actionDate>2024-12-17</actionDate>
        <sourceSystem>
          <name>Senate</name>
        </sourceSystem>
        <text>Received in the Senate.</text>
        <type>IntroReferral</type>
      </item>
      <item>
        <actionDate>2024-12-16</actionDate>
        <actionTime>16:23:02</actionTime>
        <text>Motion to reconsider laid on the table Agreed to without objection.</text>
        <type>Floor</type>
        <actionCode>H38310</actionCode>
        <sourceSystem>
          <code>2</code>
          <name>House floor actions</name>
        </sourceSystem>
      </item>
      <item>
        <actionDate>2024-12-16</actionDate>
        <actionTime>16:23:00</actionTime>
        <text>On motion to suspend the rules and pass the bill, as amended Agreed to by voice vote. (text: CR H7167-7168)</text>
        <type>Floor</type>
        <actionCode>H37300</actionCode>
        <sourceSystem>
          <code>2</code>
          <name>House floor actions</name>
        </sourceSystem>
      </item>
      <item>
        <actionDate>2024-12-16</actionDate>
        <actionTime>16:23:00</actionTime>
        <text>Passed/agreed to in House: On motion to suspend the rules and pass the bill, as amended Agreed to by voice vote. (text: CR H7167-7168)</text>
        <type>Floor</type>
        <actionCode>8000</actionCode>
        <sourceSystem>
          <code>9</code>
          <name>Library of Congress</name>
        </sourceSystem>
      </item>
      <item>
        <actionDate>2024-12-16</actionDate>
        <actionTime>16:07:15</actionTime>
        <text>DEBATE - The House proceeded with forty minutes of debate on H.R. 7188.</text>
        <type>Floor</type>
        <actionCode>H8D000</actionCode>
        <sourceSystem>
          <code>2</code>
          <name>House floor actions</name>
        </sourceSystem>
      </item>
      <item>
        <actionDate>2024-12-16</actionDate>
        <actionTime>16:07:14</actionTime>
        <text>Considered under suspension of the rules. (consideration: CR H7167-7170)</text>
        <type>Floor</type>
        <actionCode>H30000</actionCode>
        <sourceSystem>
          <code>2</code>
          <name>House floor actions</name>
        </sourceSystem>
      </item>
      <item>
        <actionDate>2024-12-16</actionDate>
        <actionTime>16:07:03</actionTime>
        <text>Mr. Bucshon moved to suspend the rules and pass the bill, as amended.</text>
        <type>Floor</type>
        <actionCode>H30300</actionCode>
        <sourceSystem>
          <code>2</code>
          <name>House floor actions</name>
        </sourceSystem>
      </item>
      <item>
        <actionDate>2024-11-22</actionDate>
        <text>Placed on the Union Calendar, Calendar No. 632.</text>
        <type>Calendars</type>
        <actionCode>H12410</actionCode>
        <sourceSystem>
          <code>2</code>
          <name>House floor actions</name>
        </sourceSystem>
      </item>
      <item>
        <actionDate>2024-11-22</actionDate>
        <text>Reported (Amended) by the Committee on Energy and Commerce. H. Rept. 118-766.</text>
        <type>Committee</type>
        <actionCode>H12200</actionCode>
        <sourceSystem>
          <code>2</code>
          <name>House floor actions</name>
        </sourceSystem>
        <committees>
          <item>
            <systemCode>hsif00</systemCode>
            <name>Energy and Commerce Committee</name>
          </item>
        </committees>
      </item>
      <item>
        <actionDate>2024-11-22</actionDate>
        <text>Reported (Amended) by the Committee on Energy and Commerce. H. Rept. 118-766.</text>
        <type>Committee</type>
        <actionCode>5000</actionCode>
        <sourceSystem>
          <code>9</code>
          <name>Library of Congress</name>
        </sourceSystem>
        <committees>
          <item>
            <systemCode>hsif00</systemCode>
            <name>Energy and Commerce Committee</name>
          </item>
        </committees>
      </item>
      <item>
        <actionDate>2024-09-18</actionDate>
        <committees>
          <item>
            <systemCode>hsif00</systemCode>
            <name>Energy and Commerce Committee</name>
          </item>
        </committees>
        <sourceSystem>
          <code>1</code>
          <name>House committee actions</name>
        </sourceSystem>
        <text>Ordered to be Reported (Amended) by the Yeas and Nays: 40 - 0.</text>
        <type>Committee</type>
      </item>
      <item>
        <actionDate>2024-09-18</actionDate>
        <committees>
          <item>
            <systemCode>hsif00</systemCode>
            <name>Energy and Commerce Committee</name>
          </item>
        </committees>
        <sourceSystem>
          <code>1</code>
          <name>House committee actions</name>
        </sourceSystem>
        <text>Committee Consideration and Mark-up Session Held</text>
        <type>Committee</type>
      </item>
      <item>
        <actionDate>2024-05-16</actionDate>
        <committees>
          <item>
            <systemCode>hsif14</systemCode>
            <name>Health Subcommittee</name>
          </item>
        </committees>
        <sourceSystem>
          <code>1</code>
          <name>House committee actions</name>
        </sourceSystem>
        <text>Forwarded by Subcommittee to Full Committee (Amended) by the Yeas and Nays: 27 - 0.</text>
        <type>Committee</type>
      </item>
      <item>
        <actionDate>2024-05-16</actionDate>
        <committees>
          <item>
            <systemCode>hsif14</systemCode>
            <name>Health Subcommittee</name>
          </item>
        </committees>
        <sourceSystem>
          <code>1</code>
          <name>House committee actions</name>
        </sourceSystem>
        <text>Subcommittee Consideration and Mark-up Session Held</text>
        <type>Committee</type>
      </item>
      <item>
        <actionDate>2024-02-02</actionDate>
        <committees>
          <item>
            <systemCode>hsif14</systemCode>
            <name>Health Subcommittee</name>
          </item>
        </committees>
        <sourceSystem>
          <code>1</code>
          <name>House committee actions</name>
        </sourceSystem>
        <text>Referred to the Subcommittee on Health.</text>
        <type>Committee</type>
      </item>
      <item>
        <actionDate>2024-02-01</actionDate>
        <text>Referred to the House Committee on Energy and Commerce.</text>
        <type>IntroReferral</type>
        <actionCode>H11100</actionCode>
        <sourceSystem>
          <code>2</code>
          <name>House floor actions</name>
        </sourceSystem>
        <committees>
          <item>
            <systemCode>hsif00</systemCode>
            <name>Energy and Commerce Committee</name>
          </item>
        </committees>
      </item>
      <item>
        <actionDate>2024-02-01</actionDate>
        <text>Introduced in House</text>
        <type>IntroReferral</type>
        <actionCode>Intro-H</actionCode>
        <sourceSystem>
          <code>9</code>
          <name>Library of Congress</name>
        </sourceSystem>
      </item>
      <item>
        <actionDate>2024-02-01</actionDate>
        <text>Introduced in House</text>
        <type>IntroReferral</type>
        <actionCode>1000</actionCode>
        <sourceSystem>
          <code>9</code>
          <name>Library of Congress</name>
        </sourceSystem>
      </item>
    </actions>
    <sponsors>
      <item>
        <bioguideId>M001194</bioguideId>
        <fullName>Rep. Moolenaar, John R. [R-MI-2]</fullName>
        <firstName>John</firstName>
        <lastName>Moolenaar</lastName>
        <party>R</party>
        <state>MI</state>
        <middleName>R.</middleName>
        <district>2</district>
        <isByRequest>N</isByRequest>
      </item>
    </sponsors>
    <cosponsors>
      <item>
        <bioguideId>D000624</bioguideId>
        <fullName>Rep. Dingell, Debbie [D-MI-6]</fullName>
        <firstName>Debbie</firstName>
        <lastName>Dingell</lastName>
        <party>D</party>
        <state>MI</state>
        <district>6</district>
        <sponsorshipDate>2024-02-01</sponsorshipDate>
        <isOriginalCosponsor>True</isOriginalCosponsor>
      </item>
    </cosponsors>
    <policyArea>
      <name>Health</name>
    </policyArea>
    <subjects>
      <legislativeSubjects>
        <item>
          <name>Administrative law and regulatory procedures</name>
          <updateDate>2024-07-02T15:27:42Z</updateDate>
        </item>
        <item>
          <name>Civil actions and liability</name>
          <updateDate>2024-07-02T15:27:24Z</updateDate>
        </item>
        <item>
          <name>Congressional oversight</name>
          <updateDate>2024-07-02T15:27:30Z</updateDate>
        </item>
        <item>
          <name>Department of Health and Human Services</name>
          <updateDate>2024-07-02T15:27:38Z</updateDate>
        </item>
        <item>
          <name>Health programs administration and funding</name>
          <updateDate>2024-07-02T15:27:20Z</updateDate>
        </item>
        <item>
          <name>Health promotion and preventive care</name>
          <updateDate>2024-07-02T15:27:09Z</updateDate>
        </item>
        <item>
          <name>Organ and tissue donation and transplantation</name>
          <updateDate>2024-07-02T15:27:13Z</updateDate>
        </item>
      </legislativeSubjects>
      <policyArea>
        <name>Health</name>
        <updateDate>2024-02-20T16:30:25Z</updateDate>
      </policyArea>
    </subjects>
    <summaries>
      <summary>
        <versionCode>00</versionCode>
        <actionDate>2024-02-01</actionDate>
        <actionDesc>Introduced in House</actionDesc>
        <updateDate>2024-12-11T17:32:58Z</updateDate>
        <cdata>
          <text>&lt;p&gt;&lt;strong&gt;Shandra Eisenga Human Cell and Tissue Product Safety Act&lt;/strong&gt;&lt;/p&gt;&lt;p&gt;This bill requires the Department of Health and Human Services (HHS) to educate the public and health care providers about the benefits and risks of transplants that use human cell or tissue products, including the risk of infections.&lt;/p&gt;&lt;p&gt;HHS must develop the educational campaign after taking into consideration information about products that carry the highest risk of transmitting infections to transplant recipients. HHS may award grants to other entities to conduct public awareness initiatives and media campaigns about the risk of infections.&amp;nbsp;&lt;/p&gt;&lt;p&gt;The bill also establishes specific civil penalties for violations of laws regarding the spread of communicable diseases and regulations regarding procedures for human cell or tissue products.&lt;/p&gt;</text>
        </cdata>
      </summary>
      <summary>
        <versionCode>07</versionCode>
        <actionDate>2024-11-22</actionDate>
        <actionDesc>Reported to House</actionDesc>
        <updateDate>2024-12-17T15:21:47Z</updateDate>
        <cdata>
          <text>&lt;p&gt;&lt;strong&gt;Shandra Eisenga Human Cell and Tissue Product Safety Act&lt;/strong&gt;&lt;/p&gt;&lt;p&gt;This bill requires federal agencies to update guidance, regulations, and educational materials about transplants involving human cell and tissue products, particularly with respect to safety and eligibility standards.&lt;/p&gt;&lt;p&gt;Specifically, the Department of Health and Human Services must support the development of educational materials for health care providers about issues relating to organ, tissue, and eye donations; screening tests; and other aspects of donations. The Food and Drug Administration (FDA) must review current guidance on donor eligibility and, if appropriate, update it with information on how to reduce the spread of tuberculosis or sepsis in association with donations. The FDA must also publish information about&amp;nbsp;its Tissue Reference Group and data about FDA inspections and registrations of human cell and tissue establishments. &lt;/p&gt;&lt;p&gt;The bill also establishes specific civil penalties for violations of regulations governing procedures for human cell and&amp;nbsp;tissue products. The FDA must consider and recommend ways to update these regulations after a public comment period.&lt;br/&gt;&lt;/p&gt;</text>
        </cdata>
      </summary>
    </summaries>
    <title>Shandra Eisenga Human Cell and Tissue Product Safety Act</title>
    <titles>
      <item>
        <titleType>Short Title(s) as Passed House</titleType>
        <titleTypeCode>104</titleTypeCode>
        <title>Shandra Eisenga Human Cell and Tissue Product Safety Act</title>
        <updateDate>2024-12-17T11:38:17Z</updateDate>
        <chamberCode>H</chamberCode>
        <chamberName>House</chamberName>
        <billTextVersionName>Engrossed in House</billTextVersionName>
        <billTextVersionCode>EH</billTextVersionCode>
      </item>
      <item>
        <titleType>Short Title(s) as Reported to House</titleType>
        <titleTypeCode>102</titleTypeCode>
        <title>Shandra Eisenga Human Cell and Tissue Product Safety Act</title>
        <updateDate>2024-11-23T08:53:15Z</updateDate>
        <chamberCode>H</chamberCode>
        <chamberName>House</chamberName>
        <billTextVersionName>Reported in House</billTextVersionName>
        <billTextVersionCode>RH</billTextVersionCode>
      </item>
      <item>
        <titleType>Display Title</titleType>
        <titleTypeCode>45</titleTypeCode>
        <title>Shandra Eisenga Human Cell and Tissue Product Safety Act</title>
        <updateDate>2024-06-11T15:45:06Z</updateDate>
      </item>
      <item>
        <titleType>Short Title(s) as Introduced</titleType>
        <titleTypeCode>101</titleTypeCode>
        <title>Shandra Eisenga Human Cell and Tissue Product Safety Act</title>
        <updateDate>2024-05-24T13:34:18Z</updateDate>
        <billTextVersionName>Introduced in House</billTextVersionName>
        <billTextVersionCode>IH</billTextVersionCode>
      </item>
      <item>
        <titleType>Official Title as Introduced</titleType>
        <titleTypeCode>6</titleTypeCode>
        <title>To require the Secretary of Health and Human Services to conduct a national, evidence-based education campaign to increase public and health care provider awareness regarding the potential risks and benefits of human cell and tissue products transplants, and for other purposes.</title>
        <updateDate>2024-03-18T22:12:33Z</updateDate>
        <billTextVersionName>Introduced in House</billTextVersionName>
        <billTextVersionCode>IH</billTextVersionCode>
      </item>
    </titles>
    <textVersions>
      <item>
        <type>Engrossed in House</type>
        <date>2024-12-16T05:00:00Z</date>
        <formats>
          <item>
            <url>https://www.govinfo.gov/content/pkg/BILLS-118hr7188eh/xml/BILLS-118hr7188eh.xml</url>
          </item>
        </formats>
      </item>
      <item>
        <type>Reported in House</type>
        <date>2024-11-22T05:00:00Z</date>
        <formats>
          <item>
            <url>https://www.govinfo.gov/content/pkg/BILLS-118hr7188rh/xml/BILLS-118hr7188rh.xml</url>
          </item>
        </formats>
      </item>
      <item>
        <type>Received in Senate</type>
        <date>2024-09-17T04:00:00Z</date>
        <formats>
          <item>
            <url>https://www.govinfo.gov/content/pkg/BILLS-118hr7188rds/xml/BILLS-118hr7188rds.xml</url>
          </item>
        </formats>
      </item>
      <item>
        <type>Introduced in House</type>
        <date>2024-02-01T05:00:00Z</date>
        <formats>
          <item>
            <url>https://www.govinfo.gov/content/pkg/BILLS-118hr7188ih/xml/BILLS-118hr7188ih.xml</url>
          </item>
        </formats>
      </item>
    </textVersions>
    <latestAction>
      <actionDate>2024-12-17</actionDate>
      <text>Received in the Senate.</text>
    </latestAction>
  </bill>
  <dublinCore xmlns:dc="http://purl.org/dc/elements/1.1/">
    <dc:format>text/xml</dc:format>
    <dc:language>EN</dc:language>
    <dc:rights>Pursuant to Title 17 Section 105 of the United States Code, this file is not subject to copyright protection and is in the public domain.</dc:rights>
    <dc:contributor>Congressional Research Service, Library of Congress</dc:contributor>
    <dc:description>This file contains bill summaries and statuses for federal legislation. A bill summary describes the most significant provisions of a piece of legislation and details the effects the legislative text may have on current law and federal programs. Bill summaries are authored by the Congressional Research Service (CRS) of the Library of Congress. As stated in Public Law 91-510 (2 USC 166 (d)(6)), one of the duties of CRS is "to prepare summaries and digests of bills and resolutions of a public general nature introduced in the Senate or House of Representatives". For more information, refer to the User Guide that accompanies this file.</dc:description>
  </dublinCore>
</billStatus>
